About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Houston | 140 Studies

Clinical Trials Brain CancerHouston

Brain Cancer Clinical Trials in Houston

Find 140 clinical trials for brain cancer near Houston, Texas. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 140 trials

CompletedTemozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00006025·Los Angeles, California and 8 others CompletedAntineoplaston Therapy in Treating Patients With Primary Malignant Brain TumorsRATIONALE: Current therapies for adults with primary malignant brain tumors that have not responded to standard therapy provide very limited benefit to the patient.NCT00003475·Houston, Texas CompletedRebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaPhase II trial to study the effectiveness of rebeccamycin analogue in treating children who have solid tumors or non-Hodgkin's lymphoma.NCT00006102·Birmingham, Alabama and 225 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedPhase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent GlioblastomaThe goal of Part I of this clinical research study is to find the highest tolerable dose of TPI 287 that can be given with bevacizumab to patients with glioblastoma.NCT01582152·Houston, Texas

WithdrawnHSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade GliomaThis study is a clinical trial to assess the efficacy and confirm the safety of intratumoral inoculation of G207 (an experimental virus therapy) combined with a single 5 Gy dose…NCT04482933·Aurora, Colorado and 4 others

TerminatedDasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed GlioblastomaPhase I: Primary Objectives: -To define the maximum tolerated dose (MTD) of dasatinib (Sprycel) with radiotherapy (RT) and 6 weeks of concomitant temozolomide (TMZ) administered…NCT00895960·Houston, Texas

WithdrawnStudying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System TumorsRATIONALE: Studying samples of cerebrospinal fluid from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer.NCT00897858·Washington D.C., District of Columbia and 7 others

TerminatedNeoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma MultiformeThis randomized phase II trial is studying how well neoadjuvant and adjuvant fenretinide works compared to adjuvant fenretinide alone in treating patients who are undergoing…NCT00075491·Houston, Texas

RecruitingStudy of Olutasidenib and Temozolomide in HGGThe goal of this study is to determine the efficacy of the study drug olutasidenib to treat newly diagnosed pediatric and young adult patients with a high-grade glioma (HGG)…NCT06161974·Aurora, Colorado and 19 others

CompletedImetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaRATIONALE: Imetelstat sodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01273090·Birmingham, Alabama and 22 others

TerminatedPhase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)Phase I Objectives: -To determine the maximum tolerated dose (MTD) of vorinostat + erlotinib versus vorinostat + erlotinib + temozolomide in adult patients with recurrent…NCT01110876·Houston, Texas

Active not recruitingA Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine GliomaPatients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer.NCT04978727·Los Angeles, California and 13 others

CompletedMeasuring Non-Enhancing Glioblastoma ProgressionThe goal of this clinical research study is to learn if magnetic resonance imaging with magnetic resonance spectroscopy ("MRI/MRS" scanning) can measure any extra growth in the…NCT00777686·Houston, Texas

TerminatedStudy to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsThe purpose of this study is to assess the safety and tolerability of VBI-1901 in subjects with recurrent malignant gliomas (glioblastoma, or GBM).NCT03382977·Irvine, California and 11 others

CompletedBlood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain TumorsThe purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 for liquid biopsy in subjects…NCT05383872·Los Angeles, California and 16 others

CompletedAdavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine GliomasThis phase I trial studies the side effects and the best dose of adavosertib when given together with local radiation therapy in treating children with newly diagnosed diffuse…NCT01922076·Birmingham, Alabama and 23 others

CompletedValproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS TumorsRATIONALE: Drugs used in chemotherapy, such as valproic acid, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00107458·Orange, California and 16 others

TerminatedA Phase 2 Study of PLX3397 in Patients With Recurrent GlioblastomaThe objective of this study is to evaluate the response of subjects with recurrent glioblastoma to continuous therapy of PLX3397.NCT01349036·Los Angeles, California and 5 others

CompletedGefitinib Plus Temozolomide in Treating Patients With Malignant Primary GliomaRATIONALE: Biological therapies such as gefitinib may interfere with the growth of cancer cells and slow the growth of the tumor.NCT00027625·Los Angeles, California and 10 others

CompletedImatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaRATIONALE: Imatinib mesylate may interfere with the growth of tumor cells and may be an effective treatment for recurrent glioma and meningioma.NCT00010049·Los Angeles, California and 10 others

Page 1 of 7Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia